A Cancer Pharmacy Podcast brought to you by The British Oncology Pharmacy Association (BOPA). The purpose of the podcast is to promote excellence in the pharmaceutical care of patients with cancer through education.
All content for Let's Talk About SACT is the property of BOPA, British oncology pharmacy association and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
A Cancer Pharmacy Podcast brought to you by The British Oncology Pharmacy Association (BOPA). The purpose of the podcast is to promote excellence in the pharmaceutical care of patients with cancer through education.
In this episode we are joined by Suzanne Frank. We discuss Inavo120 (Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer) study. We discuss the relevance of the data and how it might change practice going forward. This study is available to read at https://www.nejm.org/doi/full/10.1056/NEJMoa2404625 and the update at https://ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.1003
Let's Talk About SACT
A Cancer Pharmacy Podcast brought to you by The British Oncology Pharmacy Association (BOPA). The purpose of the podcast is to promote excellence in the pharmaceutical care of patients with cancer through education.
